Clinical Operations consulting — delivered fractionally, not theoretically.
BaseBio helps Biotechs operationally design and deliver clinical trials in Australia without building a full in-house team. Fractional Clinical Operations leadership, CRO oversight and investor-grade governance – so your study runs on time, on budget and on strategy.
We embed into your business to support, oversee and deliver clinical trials — alongside your CRO, not instead of it.
Our Services
-
Interim or part-time Head of Clinical Operations
-
Clinical Operations consultants to support delivery of your Clinical Trials
-
Trial Planning and Implementation
-
Risk Management and Crisis Handling
-
Leadership, Guidance and Motivation
-
Supports Sponsor Oversight for ICH GCP (R3)
- Supports Substance/Boots on the ground in Australia for R&D Tax requirements
Fractional Clinical Operations Leadership
Our Expertise
Early Phase, Phase II and Phase III
-
First in Human
-
SAD/MAD
-
BioSimilars
-
Food Effect
-
Oncology- Phase II-III
-
Oncology- Phase I
-
Neuroscience
-
Mental Health
-
Dermatology
-
DDI (Drug Drug Interactions)
-
Metabolic Disorders
-
Rheumatology
-
Immunology
-
Gastroenterology
-
Vaccines
-
Rare diseases
-
Urology
-
Ophthalmology
Australian Advantage
Outsourcing clinical trials to Australia delivers a powerful combination of cost efficiency, speed, and quality — when done properly.
Australia offers globally competitive R&D tax incentives that can materially reduce the cost of clinical development and extend sponsor runway. However, eligibility and compliance requirements continue to evolve. BaseBio works closely with sponsors to ensure trial design, vendor selection, and operational structures are aligned with current R&D tax guidance — maximising value while avoiding downstream risk.
Australia’s clinical trial environment is also fast and flexible. Early-phase studies can commence rapidly under the CTN/CTA framework, with no mandatory IND submission and pragmatic GMP expectations appropriate for early development. This allows sponsors to move efficiently without compromising scientific or regulatory integrity.
Just as importantly, Australia delivers quality. A mature ecosystem of experienced investigators, leading Phase I units, specialised CROs, and world-class research institutions underpin consistent, high-quality trial execution.
With the right local expertise, Australia is not just a lower-cost option — it is a strategic accelerator.
BaseBio provides on-the-ground clinical operations leadership to help sponsors place, operationalise and deliver trials in Australia with confidence.